Article: Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand.

VANCOUVER, April 4 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, announced today that the first New Zealand patient was treated with Cook Medical Inc.'s Zilver(R) PTX(TM) drug-eluting peripheral stent in December 2007. A second patient was treated in February 2008. The Zilver PTX is the world's first drug-eluting stent for peripheral arterial disease (PAD) and was recently released for sale in certain regions worldwide including New Zealand.

Under the terms of its 1997 License Agreement with Cook, Angiotech is entitled to receive royalty payments upon the commercial sale of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!